Skip to main content
. 2023 Mar 15;18:56. doi: 10.1186/s13023-023-02652-2

Table 4.

Medication use six months prior to baseline by age at enrolment

Age group, years
5–10 (N = 66) 11–15 (N = 36) 16–20 (N = 17) 21–30 (N = 22) 31–40 (N = 14) 41–50 (N = 15) 51–60 (N = 8)  ≥ 61 (N = 8)
Total medication count per patient
 n 66 36 17 22 14 15 8 8
 Mean (SD) 0.5 (1.42) 0.3 (0.73) 0.6 (0.93) 0.5 (1.41) 0.2 (0.43) 1.0 (1.60) 1.3 (1.28) 1.3 (2.05)
 Median 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5
 Min, Max 0, 8 0, 3 0, 3 0, 6 0, 1 0, 5 0, 3 0, 6
Total medication frequency, n (%)
 0 52 (78.8%) 31 (86.1%) 10 (58.8%) 17 (77.3%) 11 (78.6%) 9 (60.0%) 3 (37.5%) 4 (50.0%)
 1 5 (7.6%) 3 (8.3%) 4 (23.5%) 3 (13.6%) 3 (21.4%) 2 (13.3%) 2 (25.0%) 2 (25.0%)
 2 5 (7.6%) 0 2 (11.8%) 0 0 2 (13.3%) 1 (12.5%) 1 (12.5%)
 3 1 (1.5%) 2 (5.6%) 1 (5.9%) 1 (4.5%) 0 0 2 (25.0%) 0
  ≥ 4 3 (4.5%) 0 0 1 (4.5%) 0 2 (13.3%) 0 1 (12.5%)
ATC Level 1 Term, n (%)
 Alimentary tract and metabolism 5 (7.6%) 1 (2.8%) 0 1 (4.5%) 0 2 (13.3%) 1 (12.5%) 1 (12.5%)
 Antiinfectives for systemic use 6 (9.1%) 1 (2.8%) 3 (17.6%) 1 (4.5%) 0 0 0 0
 Blood and blood forming organs 0 1 (2.8%) 2 (11.8%) 0 2 (14.3%) 0 0 0
 Cardiovascular system 0 0 0 0 0 1 (6.7%) 1 (12.5%) 2 (25.0%)
 Dermatologicals 2 (3.0%) 0 0 0 0 1 (6.7%) 0 1 (12.5%)
 Genito-urinary system and sex hormones 0 0 1 (5.9%) 0 0 2 (13.3%) 1 (12.5%) 0
 Musculo-skeletal system 0 1 (2.8%) 1 (5.9%) 0 0 3 (20.0%) 2 (25.0%) 1 (12.5%)
 Nervous system 0 2 (5.6%) 2 (11.8%) 3 (13.6%) 0 2 (13.3%) 2 (25.0%) 1 (12.5%)
 Respiratory system 5 (7.6%) 3 (8.3%) 0 1 (4.5%) 1 (7.1%) 0 1 (12.5%) 0
 Sensory organs 2 (3.0%) 0 0 0 0 0 0 1 (12.5%)
 Systemic hormonal preparations (excluding sex hormones and insulins) 2 (3.0%) 0 0 0 0 1 (6.7%) 0 0

ATC Anatomical Therapeutic Chemical, max Maximum, min Minimum, SD Standard deviation